Project Oncology®
Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer.
Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.
Episodes 211-225 of 229
Exploring the Impacts of Race & Bias in Cancer Treatment
Project Oncology®Exploring the Impacts of Race & Bias in Cancer Treatment
Assessing Advancements in Treatment Options for Small Cell Lung Cancer
Spotlight on Lung CancerAssessing Advancements in Treatment Options for Small Cell Lung Cancer
Exploring the Treatment Landscape for Head & Neck Cancer
Project Oncology®Exploring the Treatment Landscape for Head & Neck Cancer
How COVID-19 Has Changed the Way We Approach Head & Neck Cancer Care
Project Oncology®How COVID-19 Has Changed the Way We Approach Head & Neck Cancer Care
The COVID-19 Pandemic & Dangerous Delays in Cancer Screenings
Project Oncology®The COVID-19 Pandemic & Dangerous Delays in Cancer Screenings
Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines
Project Oncology®Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines
Not Quite a Cancer Vaccine: Selling HPV & Cervical Cancer
Project Oncology®Not Quite a Cancer Vaccine: Selling HPV & Cervical Cancer
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
Project Oncology®FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
Pancreatic Cancer: The Hunt to Catch a Silent Killer
Project Oncology®Pancreatic Cancer: The Hunt to Catch a Silent Killer
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
Project Oncology®FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
Project Oncology®FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
Linking p53 Variation to Breast Cancer Risk in African American Women
Project Oncology®Linking p53 Variation to Breast Cancer Risk in African American Women
FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
Project Oncology®FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
Pancreatic Cancer: Associated Signs, Symptoms, Risk Factors and Treatment Approaches
Project Oncology®Pancreatic Cancer: Associated Signs, Symptoms, Risk Factors and Treatment Approaches
